Acurx increases authorized common stock from 200 million to 250 million shares

Acurx Pharmaceuticals, Inc.

Stockholders approved amendment at special meeting on September 16, 2025.
Authorized common stock increased from 200,000,000 to 250,000,000 shares.
Amendment filed with Delaware Secretary of State on September 22, 2025, effective immediately.
Shares may be used for future capital raising, acquisitions, or other corporate purposes.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Acurx Pharmaceuticals, Inc.: Amendment to Certificate of Incorporation to increase authorized shares of common stock from 200,000,000 to 250,000,000 (effective 2025-09-22).

Change: charter amendment
Effective: 2025-09-22

Exact text from the filing

the Company’s stockholders approved an amendment (the “Amendment”) to the Company’s Certificate of Incorporation, as amended, to increase the total number of authorized shares of the Company’s common stock from 200,000,000 to 250,000,000. On September 22, 2025, the Company filed the Amendment with the Secretary of State of the State of Delaware with immediate effect.

View on SEC.gov

Browse all governance changes →

Acurx Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-092166

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.